

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.23322938 |
| 2 | drug catabolic process (GO:0042737) | 8.84846025 |
| 3 | negative regulation of fibrinolysis (GO:0051918) | 8.41897720 |
| 4 | complement activation, alternative pathway (GO:0006957) | 8.36554411 |
| 5 | regulation of fibrinolysis (GO:0051917) | 8.32115677 |
| 6 | glyoxylate metabolic process (GO:0046487) | 8.12884602 |
| 7 | regulation of protein activation cascade (GO:2000257) | 7.86304771 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 7.80041037 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 7.58999716 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58999716 |
| 11 | omega-hydroxylase P450 pathway (GO:0097267) | 7.53893144 |
| 12 | regulation of complement activation (GO:0030449) | 7.29342870 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.01214946 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 7.01214946 |
| 15 | urea metabolic process (GO:0019627) | 6.94861325 |
| 16 | * cellular glucuronidation (GO:0052695) | 6.75110606 |
| 17 | fibrinolysis (GO:0042730) | 6.70672516 |
| 18 | * uronic acid metabolic process (GO:0006063) | 6.41433366 |
| 19 | * glucuronate metabolic process (GO:0019585) | 6.41433366 |
| 20 | nitrogen cycle metabolic process (GO:0071941) | 6.32690021 |
| 21 | protein carboxylation (GO:0018214) | 6.18712287 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.18712287 |
| 23 | bile acid biosynthetic process (GO:0006699) | 6.10797597 |
| 24 | drug metabolic process (GO:0017144) | 6.00521774 |
| 25 | oxidative demethylation (GO:0070989) | 5.95419553 |
| 26 | blood coagulation, intrinsic pathway (GO:0007597) | 5.94165808 |
| 27 | ethanol oxidation (GO:0006069) | 5.86128518 |
| 28 | urea cycle (GO:0000050) | 5.77846961 |
| 29 | negative regulation of sterol transport (GO:0032372) | 5.70484148 |
| 30 | negative regulation of cholesterol transport (GO:0032375) | 5.70484148 |
| 31 | bile acid metabolic process (GO:0008206) | 5.61164496 |
| 32 | aromatic amino acid family catabolic process (GO:0009074) | 5.56752845 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.48307939 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 5.46517305 |
| 35 | phenylpropanoid metabolic process (GO:0009698) | 5.36623543 |
| 36 | bile acid and bile salt transport (GO:0015721) | 5.27971169 |
| 37 | glycine metabolic process (GO:0006544) | 5.09540461 |
| 38 | regulation of plasminogen activation (GO:0010755) | 5.03135927 |
| 39 | protein activation cascade (GO:0072376) | 5.00453016 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.98779923 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.98779923 |
| 42 | polyketide metabolic process (GO:0030638) | 4.93000448 |
| 43 | doxorubicin metabolic process (GO:0044598) | 4.93000448 |
| 44 | daunorubicin metabolic process (GO:0044597) | 4.93000448 |
| 45 | ethanol metabolic process (GO:0006067) | 4.72473125 |
| 46 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.70325961 |
| 47 | negative regulation of protein activation cascade (GO:2000258) | 4.69714032 |
| 48 | complement activation (GO:0006956) | 4.67584974 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.63903800 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.63903800 |
| 51 | phospholipid efflux (GO:0033700) | 4.61501892 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.59078938 |
| 53 | regulation of humoral immune response (GO:0002920) | 4.58974115 |
| 54 | negative regulation of wound healing (GO:0061045) | 4.55110405 |
| 55 | S-adenosylmethionine metabolic process (GO:0046500) | 4.53559342 |
| 56 | acute-phase response (GO:0006953) | 4.53414089 |
| 57 | negative regulation of coagulation (GO:0050819) | 4.53289164 |
| 58 | complement activation, classical pathway (GO:0006958) | 4.47176118 |
| 59 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.41824069 |
| 60 | alkaloid metabolic process (GO:0009820) | 4.41688669 |
| 61 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.38198800 |
| 62 | positive regulation of blood coagulation (GO:0030194) | 4.23505465 |
| 63 | positive regulation of hemostasis (GO:1900048) | 4.23505465 |
| 64 | tyrosine metabolic process (GO:0006570) | 4.18199169 |
| 65 | flavonoid metabolic process (GO:0009812) | 4.16326634 |
| 66 | regulation of cholesterol esterification (GO:0010872) | 4.15469131 |
| 67 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.15329316 |
| 68 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.15329316 |
| 69 | negative regulation of lipase activity (GO:0060192) | 4.15107542 |
| 70 | heme transport (GO:0015886) | 4.11192961 |
| 71 | plasma lipoprotein particle remodeling (GO:0034369) | 4.10780020 |
| 72 | protein-lipid complex remodeling (GO:0034368) | 4.10780020 |
| 73 | macromolecular complex remodeling (GO:0034367) | 4.10780020 |
| 74 | serine family amino acid metabolic process (GO:0009069) | 4.10280146 |
| 75 | high-density lipoprotein particle remodeling (GO:0034375) | 4.00251425 |
| 76 | arginine metabolic process (GO:0006525) | 3.99443956 |
| 77 | intestinal cholesterol absorption (GO:0030299) | 3.95823063 |
| 78 | cholesterol efflux (GO:0033344) | 3.95719494 |
| 79 | primary alcohol catabolic process (GO:0034310) | 3.94925168 |
| 80 | cytolysis (GO:0019835) | 3.91696805 |
| 81 | positive regulation of coagulation (GO:0050820) | 3.90712812 |
| 82 | imidazole-containing compound metabolic process (GO:0052803) | 3.85692713 |
| 83 | response to mercury ion (GO:0046689) | 3.78781460 |
| 84 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.78660313 |
| 85 | indole-containing compound catabolic process (GO:0042436) | 3.76977848 |
| 86 | indolalkylamine catabolic process (GO:0046218) | 3.76977848 |
| 87 | tryptophan catabolic process (GO:0006569) | 3.76977848 |
| 88 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.75082458 |
| 89 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.75082458 |
| 90 | opsonization (GO:0008228) | 3.72712628 |
| 91 | regulation of lipoprotein particle clearance (GO:0010984) | 3.72353586 |
| 92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.71986622 |
| 93 | negative regulation of complement activation (GO:0045916) | 3.70710831 |
| 94 | alpha-amino acid catabolic process (GO:1901606) | 3.70505655 |
| 95 | aromatic amino acid family metabolic process (GO:0009072) | 3.62025144 |
| 96 | sodium-independent organic anion transport (GO:0043252) | 3.59813367 |
| 97 | reverse cholesterol transport (GO:0043691) | 3.56445039 |
| 98 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.55574844 |
| 99 | * xenobiotic metabolic process (GO:0006805) | 3.54659875 |
| 100 | drug transmembrane transport (GO:0006855) | 3.54255174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.13992919 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.00217948 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.85613233 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.63289088 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.90737444 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.88809269 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.30403157 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.26651747 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.09121171 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.41800535 |
| 11 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.16689150 |
| 12 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.11293783 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10230288 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01273033 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1294378 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75062772 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.69947091 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.62265001 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40798115 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24578275 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21413527 |
| 22 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.20554239 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16930818 |
| 24 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14851521 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12538642 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08731502 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06807241 |
| 28 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.01991181 |
| 29 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.00877698 |
| 30 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97715346 |
| 31 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96790498 |
| 32 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.96202221 |
| 33 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95955269 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94831550 |
| 35 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.92990692 |
| 36 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91423570 |
| 37 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90890191 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88844033 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87483362 |
| 40 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.86448404 |
| 41 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86389839 |
| 42 | NFYA_21822215_ChIP-Seq_K562_Human | 0.85621223 |
| 43 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.84850200 |
| 44 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83214062 |
| 45 | CBP_21632823_ChIP-Seq_H3396_Human | 0.82751893 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80913052 |
| 47 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80432668 |
| 48 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79030138 |
| 49 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.78926354 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77875597 |
| 51 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.77144581 |
| 52 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77011015 |
| 53 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.76790048 |
| 54 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.75721654 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.75072406 |
| 56 | AR_20517297_ChIP-Seq_VCAP_Human | 0.74862026 |
| 57 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.74199501 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73561576 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.72057961 |
| 60 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.71908440 |
| 61 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.71710065 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.71149613 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.70238036 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70049377 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69919373 |
| 66 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.69056002 |
| 67 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68643871 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.68116332 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.67980513 |
| 70 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.67321850 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66815750 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66815750 |
| 73 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.66689224 |
| 74 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.66157845 |
| 75 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.66081960 |
| 76 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.65100038 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64660063 |
| 78 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.63768910 |
| 79 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.63221331 |
| 80 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.62068429 |
| 81 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.61906552 |
| 82 | NFYB_21822215_ChIP-Seq_K562_Human | 0.61134941 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.61018476 |
| 84 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.59859263 |
| 85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58470581 |
| 86 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.58436808 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.57581831 |
| 88 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.56728718 |
| 89 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.56708840 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.56152134 |
| 91 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.55977798 |
| 92 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.55899117 |
| 93 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.53632424 |
| 94 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.53520350 |
| 95 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.53520350 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.53147091 |
| 97 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.53048300 |
| 98 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.52662205 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.52541337 |
| 100 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.52533887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005085_abnormal_gallbladder_physiolo | 6.43753899 |
| 2 | MP0005365_abnormal_bile_salt | 6.07247398 |
| 3 | MP0005360_urolithiasis | 5.91855730 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.28807657 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 4.85650112 |
| 6 | MP0003195_calcinosis | 4.84355387 |
| 7 | MP0003252_abnormal_bile_duct | 4.45283836 |
| 8 | MP0003868_abnormal_feces_composition | 3.77731982 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.30938625 |
| 10 | MP0009697_abnormal_copulation | 3.01063049 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.68745817 |
| 12 | MP0009840_abnormal_foam_cell | 2.30759525 |
| 13 | MP0005332_abnormal_amino_acid | 2.29677253 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.29318267 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.23002681 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 10.0522757 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 1.89516922 |
| 18 | MP0000609_abnormal_liver_physiology | 1.86355070 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.68880238 |
| 20 | MP0001764_abnormal_homeostasis | 1.67033287 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.34593320 |
| 22 | MP0005408_hypopigmentation | 1.31270845 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.30382349 |
| 24 | MP0001661_extended_life_span | 1.27946458 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.21551901 |
| 26 | MP0009053_abnormal_anal_canal | 1.09985557 |
| 27 | MP0000598_abnormal_liver_morphology | 1.04213285 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02531830 |
| 29 | MP0009643_abnormal_urine_homeostasis | 0.96579708 |
| 30 | MP0003186_abnormal_redox_activity | 0.94710143 |
| 31 | MP0000604_amyloidosis | 0.93230525 |
| 32 | MP0005187_abnormal_penis_morphology | 0.92003959 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 0.91133520 |
| 34 | MP0001915_intracranial_hemorrhage | 0.84319321 |
| 35 | MP0009642_abnormal_blood_homeostasis | 0.83596300 |
| 36 | MP0005451_abnormal_body_composition | 0.83101220 |
| 37 | MP0002132_abnormal_respiratory_system | 0.82831973 |
| 38 | MP0008469_abnormal_protein_level | 0.82684536 |
| 39 | MP0005670_abnormal_white_adipose | 0.81877109 |
| 40 | MP0005376_homeostasis/metabolism_phenot | 0.81746964 |
| 41 | MP0009763_increased_sensitivity_to | 0.79642518 |
| 42 | MP0009764_decreased_sensitivity_to | 0.76428412 |
| 43 | MP0002971_abnormal_brown_adipose | 0.74235296 |
| 44 | MP0005395_other_phenotype | 0.72208105 |
| 45 | MP0003011_delayed_dark_adaptation | 0.72000937 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 0.71710979 |
| 47 | MP0005464_abnormal_platelet_physiology | 0.70448894 |
| 48 | MP0003638_abnormal_response/metabolism_ | 0.67484010 |
| 49 | MP0003690_abnormal_glial_cell | 0.66035740 |
| 50 | MP0003879_abnormal_hair_cell | 0.63578375 |
| 51 | MP0002168_other_aberrant_phenotype | 0.62152381 |
| 52 | MP0005535_abnormal_body_temperature | 0.58104369 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 0.55838025 |
| 54 | MP0005266_abnormal_metabolism | 0.54632294 |
| 55 | MP0008874_decreased_physiological_sensi | 0.52987123 |
| 56 | MP0005023_abnormal_wound_healing | 0.51992284 |
| 57 | MP0002282_abnormal_trachea_morphology | 0.51356798 |
| 58 | MP0005334_abnormal_fat_pad | 0.46763079 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 0.45812745 |
| 60 | MP0009785_altered_susceptibility_to | 0.44584645 |
| 61 | MP0008872_abnormal_physiological_respon | 0.41638278 |
| 62 | MP0003959_abnormal_lean_body | 0.41269073 |
| 63 | MP0005164_abnormal_response_to | 0.40540012 |
| 64 | MP0000249_abnormal_blood_vessel | 0.39932929 |
| 65 | MP0002249_abnormal_larynx_morphology | 0.38785355 |
| 66 | MP0005058_abnormal_lysosome_morphology | 0.37986703 |
| 67 | MP0004883_abnormal_blood_vessel | 0.34643043 |
| 68 | MP0004130_abnormal_muscle_cell | 0.32575299 |
| 69 | MP0002136_abnormal_kidney_physiology | 0.32237982 |
| 70 | MP0002928_abnormal_bile_duct | 0.31484803 |
| 71 | MP0005647_abnormal_sex_gland | 0.31314866 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 0.29504407 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 0.28879802 |
| 74 | MP0005448_abnormal_energy_balance | 0.28554534 |
| 75 | MP0003953_abnormal_hormone_level | 0.26434212 |
| 76 | MP0005166_decreased_susceptibility_to | 0.26288538 |
| 77 | MP0009115_abnormal_fat_cell | 0.25260733 |
| 78 | MP0005197_abnormal_uvea_morphology | 0.24770627 |
| 79 | MP0003718_maternal_effect | 0.24624904 |
| 80 | MP0000920_abnormal_myelination | 0.24304294 |
| 81 | MP0008873_increased_physiological_sensi | 0.24293696 |
| 82 | MP0001851_eye_inflammation | 0.23921252 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.22464314 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.22295712 |
| 85 | MP0000467_abnormal_esophagus_morphology | 0.21958120 |
| 86 | MP0001756_abnormal_urination | 0.21921039 |
| 87 | MP0003632_abnormal_nervous_system | 0.21759144 |
| 88 | MP0003075_altered_response_to | 0.21159137 |
| 89 | MP0002090_abnormal_vision | 0.20091989 |
| 90 | MP0003633_abnormal_nervous_system | 0.19590483 |
| 91 | MP0000566_synostosis | 0.19514845 |
| 92 | MP0004142_abnormal_muscle_tone | 0.19234926 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.18488833 |
| 94 | MP0002970_abnormal_white_adipose | 0.18140246 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 0.18072044 |
| 96 | MP0002128_abnormal_blood_circulation | 0.17452583 |
| 97 | MP0003631_nervous_system_phenotype | 0.16806206 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.16511893 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.15973123 |
| 100 | MP0004272_abnormal_basement_membrane | 0.15353380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 9.38638072 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.51619046 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 8.02983983 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.83247324 |
| 5 | Abnormality of complement system (HP:0005339) | 7.58881123 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 7.31096097 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 5.96850828 |
| 8 | Glomerulonephritis (HP:0000099) | 5.86112463 |
| 9 | Joint hemorrhage (HP:0005261) | 5.78206299 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.65527903 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 5.55881564 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.26880104 |
| 13 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.90779256 |
| 14 | Spontaneous abortion (HP:0005268) | 4.82014421 |
| 15 | Xanthomatosis (HP:0000991) | 4.73627606 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.59130236 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.13629636 |
| 18 | Nephritis (HP:0000123) | 4.11112692 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.93592367 |
| 20 | Fat malabsorption (HP:0002630) | 3.82010922 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.74331413 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.66801588 |
| 23 | Generalized aminoaciduria (HP:0002909) | 3.38859212 |
| 24 | Gingival bleeding (HP:0000225) | 3.31405128 |
| 25 | Hyperammonemia (HP:0001987) | 3.29747850 |
| 26 | Hyperglycinemia (HP:0002154) | 3.26175670 |
| 27 | Rickets (HP:0002748) | 3.13761050 |
| 28 | Steatorrhea (HP:0002570) | 3.07593932 |
| 29 | Osteomalacia (HP:0002749) | 2.95833721 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 2.94213382 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 2.90699859 |
| 32 | Hypercholesterolemia (HP:0003124) | 2.85076475 |
| 33 | Vascular calcification (HP:0004934) | 2.83231023 |
| 34 | Mitral stenosis (HP:0001718) | 2.83023694 |
| 35 | Hyperbilirubinemia (HP:0002904) | 2.76978376 |
| 36 | Delayed CNS myelination (HP:0002188) | 2.76963513 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.72675662 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 2.72675662 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.72674267 |
| 40 | Hemorrhage of the eye (HP:0011885) | 2.64687283 |
| 41 | Thrombophlebitis (HP:0004418) | 2.64191436 |
| 42 | Reduced antithrombin III activity (HP:0001976) | 2.63736133 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.58852494 |
| 44 | Purpura (HP:0000979) | 2.57879439 |
| 45 | Epidermoid cyst (HP:0200040) | 2.52962675 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.51331223 |
| 47 | Hyperglycinuria (HP:0003108) | 2.51050806 |
| 48 | Cardiovascular calcification (HP:0011915) | 2.50364075 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.41247450 |
| 50 | Cholecystitis (HP:0001082) | 2.41247450 |
| 51 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.39863470 |
| 52 | Pulmonary embolism (HP:0002204) | 2.38570856 |
| 53 | Fair hair (HP:0002286) | 2.32819737 |
| 54 | Menorrhagia (HP:0000132) | 2.31184417 |
| 55 | Hyperphosphaturia (HP:0003109) | 2.25836009 |
| 56 | Abnormality of vitamin metabolism (HP:0100508) | 2.23724992 |
| 57 | Cholelithiasis (HP:0001081) | 2.20883619 |
| 58 | Glycosuria (HP:0003076) | 2.15455526 |
| 59 | Abnormality of urine glucose concentration (HP:0011016) | 2.15455526 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.10683718 |
| 61 | Metabolic acidosis (HP:0001942) | 2.09457103 |
| 62 | Arthropathy (HP:0003040) | 2.07716612 |
| 63 | Elevated alkaline phosphatase (HP:0003155) | 2.07482936 |
| 64 | Joint swelling (HP:0001386) | 2.07280113 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.05557521 |
| 66 | Abnormality of the Achilles tendon (HP:0005109) | 2.00906659 |
| 67 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.2312902 |
| 68 | Deep venous thrombosis (HP:0002625) | 10.0108129 |
| 69 | Irritability (HP:0000737) | 1.99343659 |
| 70 | Bifid scrotum (HP:0000048) | 1.95384533 |
| 71 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91658446 |
| 72 | Abnormal biliary tract physiology (HP:0012439) | 1.90673286 |
| 73 | Bile duct proliferation (HP:0001408) | 1.90673286 |
| 74 | Neonatal hypoglycemia (HP:0001998) | 1.86727424 |
| 75 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.86468550 |
| 76 | Abnormality of iron homeostasis (HP:0011031) | 1.85420359 |
| 77 | Increased serum ferritin (HP:0003281) | 1.83758664 |
| 78 | Myocardial infarction (HP:0001658) | 1.82820705 |
| 79 | Abnormal urine phosphate concentration (HP:0012599) | 1.81983034 |
| 80 | Gangrene (HP:0100758) | 1.81387918 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 1.81192833 |
| 82 | Abnormality of proline metabolism (HP:0010907) | 1.79145091 |
| 83 | Hydroxyprolinuria (HP:0003080) | 1.79145091 |
| 84 | Ketosis (HP:0001946) | 1.78057381 |
| 85 | Hypophosphatemic rickets (HP:0004912) | 1.78027912 |
| 86 | Poikilocytosis (HP:0004447) | 1.73187540 |
| 87 | Abnormality of purine metabolism (HP:0004352) | 1.72709481 |
| 88 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70958531 |
| 89 | Increased mean platelet volume (HP:0011877) | 1.68849592 |
| 90 | Epistaxis (HP:0000421) | 1.68297671 |
| 91 | Cerebral palsy (HP:0100021) | 1.67746838 |
| 92 | Abnormal delivery (HP:0001787) | 1.61705607 |
| 93 | Pancreatitis (HP:0001733) | 1.59651731 |
| 94 | Lethargy (HP:0001254) | 1.58296091 |
| 95 | Generalized hypopigmentation of hair (HP:0011358) | 1.58237091 |
| 96 | Sensorimotor neuropathy (HP:0007141) | 1.55281776 |
| 97 | Abnormality of the gallbladder (HP:0005264) | 1.54911020 |
| 98 | Atrioventricular block (HP:0001678) | 1.54786216 |
| 99 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.51066504 |
| 100 | Alkalosis (HP:0001948) | 1.50780868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 5.14602304 |
| 2 | ERN1 | 4.60458725 |
| 3 | FGFR4 | 3.74429943 |
| 4 | RIPK1 | 3.17854255 |
| 5 | PRKACG | 2.30873238 |
| 6 | TYK2 | 2.29187077 |
| 7 | PIK3CA | 2.19058782 |
| 8 | BCKDK | 2.10260228 |
| 9 | EPHA3 | 2.03852826 |
| 10 | TBK1 | 1.95730394 |
| 11 | FGFR3 | 1.87095126 |
| 12 | SIK1 | 1.79317326 |
| 13 | PRKAA2 | 1.78175887 |
| 14 | MAP3K12 | 1.76935800 |
| 15 | MAP3K3 | 1.75919966 |
| 16 | MST1R | 1.74160973 |
| 17 | PRKCG | 1.74050444 |
| 18 | IRAK3 | 1.70215323 |
| 19 | MAPK11 | 1.69940374 |
| 20 | MAP2K4 | 1.69306884 |
| 21 | NEK9 | 1.67585935 |
| 22 | PINK1 | 1.56189369 |
| 23 | TRIB3 | 1.53978374 |
| 24 | ABL2 | 1.52967655 |
| 25 | FRK | 1.52502648 |
| 26 | PRPF4B | 1.51517227 |
| 27 | NTRK3 | 1.50067715 |
| 28 | MYLK | 1.49930800 |
| 29 | IGF1R | 1.36588258 |
| 30 | ERBB4 | 1.34900381 |
| 31 | TAOK3 | 1.32414364 |
| 32 | MAP3K2 | 1.25422089 |
| 33 | JAK1 | 1.23336606 |
| 34 | PDPK1 | 1.17904705 |
| 35 | NLK | 1.12567638 |
| 36 | CAMKK2 | 1.07222440 |
| 37 | MET | 1.06998451 |
| 38 | PRKCZ | 1.05437528 |
| 39 | ICK | 1.05356108 |
| 40 | FER | 1.00973496 |
| 41 | SCYL2 | 0.99729581 |
| 42 | PRKG1 | 0.98710832 |
| 43 | JAK2 | 0.95937918 |
| 44 | PRKAA1 | 0.93371088 |
| 45 | ZAP70 | 0.89352980 |
| 46 | ERBB2 | 0.88295730 |
| 47 | PRKACA | 0.87087776 |
| 48 | TNK2 | 0.86184605 |
| 49 | CASK | 0.84267780 |
| 50 | INSRR | 0.82185323 |
| 51 | PDK1 | 0.81903590 |
| 52 | MAP3K1 | 0.81654655 |
| 53 | CSNK1D | 0.81603257 |
| 54 | EPHA4 | 0.79240358 |
| 55 | EIF2AK1 | 0.76956040 |
| 56 | STK38 | 0.72687954 |
| 57 | ACVR1B | 0.71876885 |
| 58 | PRKCB | 0.69616726 |
| 59 | MAP3K5 | 0.68097283 |
| 60 | WNK3 | 0.67533502 |
| 61 | CDK6 | 0.67016463 |
| 62 | MAP3K6 | 0.66657707 |
| 63 | PDK2 | 0.66625152 |
| 64 | CSNK1E | 0.66471091 |
| 65 | PRKCA | 0.64239102 |
| 66 | RET | 0.63860221 |
| 67 | MAP2K3 | 0.61805542 |
| 68 | RPS6KA3 | 0.61103581 |
| 69 | NEK1 | 0.58906689 |
| 70 | CSF1R | 0.58285917 |
| 71 | MAP3K11 | 0.56505963 |
| 72 | SGK1 | 0.55666078 |
| 73 | PRKACB | 0.55665922 |
| 74 | STK16 | 0.55491484 |
| 75 | MUSK | 0.53774358 |
| 76 | DAPK2 | 0.53013648 |
| 77 | CAMK1D | 0.52029629 |
| 78 | GRK1 | 0.51010088 |
| 79 | EPHB1 | 0.50902317 |
| 80 | MAPKAPK3 | 0.49618781 |
| 81 | TGFBR2 | 0.49392421 |
| 82 | CAMKK1 | 0.49172150 |
| 83 | GSK3A | 0.48452531 |
| 84 | SRC | 0.46593380 |
| 85 | SGK494 | 0.45205455 |
| 86 | SGK223 | 0.45205455 |
| 87 | TAOK2 | 0.43942294 |
| 88 | PAK3 | 0.42279320 |
| 89 | CSNK2A1 | 0.41572249 |
| 90 | PRKCE | 0.40541616 |
| 91 | TIE1 | 0.40063451 |
| 92 | KSR2 | 0.40016768 |
| 93 | CAMK2G | 0.39452492 |
| 94 | BCR | 0.39372094 |
| 95 | DYRK1B | 0.38483950 |
| 96 | PDGFRA | 0.38113873 |
| 97 | PKN2 | 0.37390589 |
| 98 | SGK3 | 0.36564580 |
| 99 | CSNK2A2 | 0.36546176 |
| 100 | MAPK4 | 0.36057521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.12667571 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.07552218 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.05830225 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.96058184 |
| 5 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.66422380 |
| 6 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.39264819 |
| 7 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.37395564 |
| 8 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.89836134 |
| 9 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.88762259 |
| 10 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.86122587 |
| 11 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.77274004 |
| 12 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.69173591 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.66362180 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.38840019 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.33870718 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31524522 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.14398480 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08394376 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.07626685 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.86284816 |
| 21 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.83767621 |
| 22 | * Bile secretion_Homo sapiens_hsa04976 | 1.76646198 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75001883 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.74476921 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59175194 |
| 26 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56311935 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.47239703 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40130329 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.38657671 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37998281 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.36019909 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32941265 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30705388 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27352755 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26986361 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22519587 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20280490 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13004861 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08108998 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05845135 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.05513490 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.01535088 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95314029 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94988360 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89001882 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86682546 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85630100 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.84269866 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82707614 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80110049 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72752410 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72030420 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70011545 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67067953 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64196134 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64038182 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.53002403 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47885319 |
| 59 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42912351 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32368798 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.31321112 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30176277 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28565633 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27444554 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23218221 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22206206 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21785444 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17935863 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.17658703 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17574984 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14629887 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.13104218 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.12076940 |
| 74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.11818424 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.09724448 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07745283 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.06605770 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06327527 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.04487043 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.01229448 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.00149402 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2625910 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2569306 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2392496 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2256264 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2122756 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.1914939 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1904309 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1813163 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1541597 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1477826 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1398153 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1396885 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1264879 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1129698 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | -0.1115260 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0900001 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | -0.0805251 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0499107 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0157997 |

